Comparative effect of body-mass index on outcome with targeted therapy and immunotherapy in patients with metastatic renal cell carcinoma (mRCC)

被引：0
|
作者：
Dizman, N. [1 ]
Bergerot, P. [1 ]
Bergerot, C. D. [1 ]
Philip, E. J. [2 ]
Salgia, M. M. [1 ]
Hsu, J. [1 ]
Adashek, J. [1 ]
Pal, S. K. [1 ]
机构：
[1] City Hope Natl Med Ctr, Med Oncol, Duarte, CA USA
[2] Univ Notre Dame, Notre Dame Lab Psychooncol Res, Notre Dame, IN 46556 USA
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
894P
引用
收藏
页码：318 / 318
页数：1
相关论文
共 50 条
  • [1] Targeted Therapy and Immunotherapy: Effect of Body Mass Index on Clinical Outcomes in Patients Diagnosed with Metastatic Renal Cell Carcinoma
    Bergerot, Paulo Gustavo
    Bergerot, Cristiane Decat
    Philip, Errol J.
    Meza, Luis
    Dizman, Nazli
    Hsu, JoAnn
    Pal, Sumanta Kumar
    [J]. KIDNEY CANCER, 2019, 3 (01) : 63 - 70
  • [2] The impact of body mass index (BMI) on treatment outcome of targeted therapy in metastatic renal cell carcinoma (mRCC): Results from the International Metastatic Renal Cell Cancer Database Consortium
    Albiges, Laurence
    Xie, Wanling
    Lee, Jae-Lyun
    Rini, Brian I.
    Srinivas, Sandy
    Bjarnason, Georg A.
    Ernst, D. Scott
    Wood, Lori
    Vaishamayan, Ulka N.
    Rha, Sun Young
    Agarwal, Neeraj
    Yuasa, Takeshi
    Pal, Sumanta Kumar
    Koutsoukos, Konstantinos
    Fay, Andre Poisl
    Preston, Mark A.
    Cho, Eunyoung
    Heng, Daniel Yick Chin
    Choueiri, Toni K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [3] Association of body mass index (BMI) with survival outcomes in patients with metastatic renal cell carcinoma (mRCC)
    Goswamy, Rohit Vivek
    Yildirim, Ahmet
    Choi, Yujin
    Wei, Mengting
    Liu, Yuan
    Brown, Jacqueline T.
    Nazha, Bassel
    Martini, Dylan J.
    Hartman, Caitlin
    McClintock, Greta Russler
    Zhuang, Tony
    Kissick, Haydn
    Harris, Wayne Bernard
    Carthon, Bradley Curtis
    Kucuk, Omer
    Master, Viraj A.
    Bilen, Mehmet Asim
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [4] Distinct cytokines predict response to immunotherapy and targeted therapy in metastatic renal cell carcinoma (mRCC).
    Chehrazi-Raffle, Alex
    Meza, Luis A.
    Alcantara, Marice
    Salgia, Nicholas
    Dizman, Nazli
    Bergerot, Paulo Gustavo
    Hsu, Joann
    Kortylewski, Marcin
    Pal, Sumanta K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [5] Outcome of metastatic renal cell carcinoma (mRCC) patients in the era of new targeted therapies
    Ruiz, A. L.
    Bolos, M. V.
    Viqueira, A.
    Esteban, E.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S654 - S654
  • [6] Cessation of VEGF-targeted therapy in patients with metastatic renal cell carcinoma (mRCC): Feasibility and clinical outcome
    Sadeghi, S.
    Albiges, L.
    Wood, L. S.
    Black, S. L.
    Gilligan, T. D.
    Dreicer, R.
    Garcia, J. A.
    Escudier, B. J.
    Rini, B. I.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [7] Brain metastases in patients treated with targeted therapy for metastatic renal cell carcinoma (mRCC)
    Alharbi, H.
    Choueiri, T. K.
    Kollmannsberger, C. K.
    North, S.
    MacKenzie, M. J.
    Knox, J. J.
    Rini, B. I.
    Heng, D. Y.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [8] Outcome of patients with metastatic renal cell carcinoma (mRCC) treated with targeted therapy (TT) without cytoreductive nephrectomy (CN)
    Richey, S. L.
    Culp, S. H.
    Jonasch, E.
    Corn, P. G.
    Pagliaro, L. C.
    Matin, S. F.
    Wood, C. G.
    Tannir, N. M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [9] Impact of tumor size on survival outcome in metastatic renal cell carcinoma patients (mRCC) treated with targeted therapy.
    Xie, Wanling
    DiNatale, Renzo
    Hakimi, A. Ari
    Donskov, Frede
    Porta, Camillo
    Reaume, M. Neil
    Basappa, Naveen S.
    Hansen, Aaron Richard
    Rini, Brian I.
    Beuselinck, Benoit
    Bjarnason, Georg A.
    Srinivas, Sandy
    Brugarolas, James
    Rha, Sun Young
    Wood, Lori
    Lalani, Aly-Khan A.
    Bosse, Dominick
    Duquette, Audrey
    Heng, Daniel Yick Chin
    Choueiri, Toni K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [10] Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis
    McQuade, Jennifer L.
    Daniel, Carrie R.
    Hess, Kenneth R.
    Mak, Carmen
    Wang, Daniel Y.
    Rai, Rajat R.
    Park, John J.
    Haydu, Lauren E.
    Spencer, Christine
    Wongchenko, Matthew
    Lane, Stephen
    Lee, Dung-Yang
    Kaper, Mathilde
    McKean, Meredith
    Beckermann, Kathryn E.
    Rubinstein, Samuel M.
    Rooney, Isabelle
    Musib, Luna
    Budha, Nageshwar
    Hsu, Jessie
    Nowicki, Theodore S.
    Avila, Alexandre
    Haas, Tomas
    Puligandla, Maneka
    Lee, Sandra
    Fang, Shenying
    Wargo, Jennifer A.
    Gershenwald, Jeffrey E.
    Lee, Jeffrey E.
    Hwu, Patrick
    Chapman, Paul B.
    Sosman, Jeffrey A.
    Schadendorf, Dirk
    Grob, Jean-Jacques
    Flaherty, Keith T.
    Walker, Dana
    Yan, Yibing
    McKenna, Edward
    Legos, Jeffrey J.
    Carlino, Matteo S.
    Ribas, Antoni
    Kirkwood, John M.
    Long, Georgina V.
    Johnson, Douglas B.
    Menzies, Alexander M.
    Davies, Michael A.
    [J]. LANCET ONCOLOGY, 2018, 19 (03): : 310 - 322
12345